Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Pharmaceutical Technology Europe ; 34(9):9-12, 2022.
Article in English | ProQuest Central | ID: covidwho-20243212

ABSTRACT

Recognizing reality, Uwe Schoenbeck, PhD, senior vice president and chief scientific officer for Emerging Science & Innovation (ES&I) at Pfizer, has synthesized and made functional core lessons from two of the past decade's best business books: According to Schoenbeck, ESLs are highly experienced in the relevant disease area and embedded within the respective therapeutic areas, resulting in high strategic alignment of the opportunity being sourced and avoiding opportunities that are not a strategic fit (1). The ES&I team, in conjunction with colleagues working in Business Development, has stood out for bringing genuinely creative partnership ideas and innovations into an already creative and crowded environment. [...]a collaboration with Codex DNA will potentially streamline the mRNA production process by facilitating synthetic DNA assembly, another notable fruit of the team's labour to bring forth a competitive pipeline in gene therapy.

2.
Pharmaceutical Technology Europe ; 33(10):6, 2021.
Article in English | ProQuest Central | ID: covidwho-20243211
3.
BioPharm International ; 36(1):45083.0, 2023.
Article in English | CINAHL | ID: covidwho-2245417

ABSTRACT

In this article author focuses on perspective and context on various international pharmacopoeias and regulatory requirements, monographs, reference standards, and protocols.

SELECTION OF CITATIONS
SEARCH DETAIL